Hengkang Medical Group Co Ltd
SZSE:002219

Watchlist Manager
Hengkang Medical Group Co Ltd Logo
Hengkang Medical Group Co Ltd
SZSE:002219
Watchlist
Price: 2.87 CNY -10.03% Market Closed
Market Cap: 9.4B CNY
Have any thoughts about
Hengkang Medical Group Co Ltd?
Write Note
Hengkang Medical Group Co Ltd
/
Balance Sheet
/
Cash & Cash Equivalents

Hengkang Medical Group Co Ltd
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Hengkang Medical Group Co Ltd
Cash & Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Hengkang Medical Group Co Ltd
SZSE:002219
Cash & Cash Equivalents
¥449.3m
CAGR 3-Years
28%
CAGR 5-Years
22%
CAGR 10-Years
12%
H
Hygeia Healthcare Holdings Co Ltd
HKEX:6078
Cash & Cash Equivalents
¥853.8m
CAGR 3-Years
30%
CAGR 5-Years
35%
CAGR 10-Years
N/A
A
Aier Eye Hospital Group Co Ltd
SZSE:300015
Cash & Cash Equivalents
¥5.5B
CAGR 3-Years
5%
CAGR 5-Years
26%
CAGR 10-Years
24%
X
XiAn International Medical Investment Co Ltd
SZSE:000516
Cash & Cash Equivalents
¥667.3m
CAGR 3-Years
-3%
CAGR 5-Years
-13%
CAGR 10-Years
-3%
H
Huaxia Eye Hospital Group Co Ltd
SZSE:301267
Cash & Cash Equivalents
¥3.9B
CAGR 3-Years
98%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Sanbo Hospital Management Group Ltd
SZSE:301293
Cash & Cash Equivalents
¥822.1m
CAGR 3-Years
16%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Hengkang Medical Group Co Ltd
Glance View

Market Cap
9.8B CNY
Industry
Health Care

Hengkang Medical Group Co Ltd. stands as a testament to the burgeoning evolution of healthcare in China. Founded with a vision to modernize traditional healthcare systems, the company has woven an intricate network of hospitals and healthcare services across the country, tapping into the ever-growing demand for quality medical care. At the heart of Hengkang's operations is its commitment to providing comprehensive medical services—from outpatient and inpatient care to specialized treatments—all under one roof. This vertically integrated approach not only ensures seamless delivery of care but also drives efficiencies through economies of scale. By investing in advanced medical technologies and skilled professionals, Hengkang positions itself as a leader in the healthcare landscape, providing services that cater to diverse medical needs, thereby consistently drawing a steady stream of patients and insurance collaborations. What sets Hengkang apart is its keen focus on aligning healthcare delivery with digital transformation. The company leverages digital platforms to streamline its operations, enhance patient experiences, and optimize resource allocation. This digital shift plays a crucial role in its revenue model—Hengkang taps into data analytics to provide value-added services, optimize operational workflows, and predict healthcare trends, which not only improve patient outcomes but also drive profitability. Furthermore, its portfolio extends beyond clinical care; the group actively engages in partnering with biotech research initiatives and health management programs, broadening its reach and reinforcing its market position as an integrated healthcare service provider. This multifaceted strategy ensures Hengkang's resilience and adaptability in an ever-changing industry, catalyzing its growth and solidifying its reputation as a beacon of modern healthcare.

Intrinsic Value
2.26 CNY
Overvaluation 21%
Intrinsic Value
Price
What is Intrinsic Value?

See Also

What is Hengkang Medical Group Co Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
449.3m CNY

Based on the financial report for Sep 30, 2024, Hengkang Medical Group Co Ltd's Cash & Cash Equivalents amounts to 449.3m CNY.

What is Hengkang Medical Group Co Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
12%

Over the last year, the Cash & Cash Equivalents growth was -24%. The average annual Cash & Cash Equivalents growth rates for Hengkang Medical Group Co Ltd have been 28% over the past three years , 22% over the past five years , and 12% over the past ten years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 211,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.